The combination of tephrosin with 2-deoxy-D-glucose enhances the cytotoxicity via accelerating ATP depletion and blunting autophagy in human cancer cells

Cancer Biology and Therapy

Volumn 12, Issue 11, 2011, Pages 989-996

  Choi, Yunjin ^a   Lee, Jeong Hyung ^a  

^a Kangwon National University   (South Korea)

Author keywords

2 Deoxy D glucose; Apoptosis; Autophagy; Elongation factor 2 kinase; Tephrosin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; DEOXYGLUCOSE; ELONGATION FACTOR 2 KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; SMALL INTERFERING RNA; TEPHROSIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN HT29; CELL SURVIVAL; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; LUNG CANCER; MOLECULARLY TARGETED THERAPY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL SURVIVAL; DEOXYGLUCOSE; ELONGATION FACTOR 2 KINASE; ENZYME ACTIVATION; HUMANS; INTRACELLULAR SPACE; NEOPLASMS; ROTENONE;

EID: 82755195287     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.11.18364     Document Type: Article

References (38)

1. Warburg O. On respiratory impairment in cancer cells. Science 1956; 124:269-70; PMID:13351639
2. Warburg O. On the origin of cancer cells. Science 1956; 123:309-14; PMID:13298683; http://dx.doi.org/10.1126/science.123.3191.309
3. Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell 2011; 144:646-74; PMID: 21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
4. Brown J. Effects of 2-deoxyglucose on carbohydrate metablism: review of the literature and studies in the rat. Metabolism 1962; 11:1098-112; PMID: 13873661
5. Parniak M, Kalant N. Incorporation of glucose into glycogen in primary cultures of rat hepatocytes. Can J Biochem Cell Biol 1985; 63:333-40; PMID:3893656; http://dx.doi.org/10.1139/o85-049
6. McComb RB, Yushok WD. Metabolism of ascites tumor cells: IV. Enzymatic reactions involved in adenosine triphosphate degradation induced by 2-deoxyglucose. Cancer Res 1964; 24:198-205; PMID:14115684
7. Karczmar GS, Arbeit JM, Toy BJ, Speder A, Weiner MW. Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy. Cancer Res 1992; 52:71-6; PMID:1727388
8. Zhang XD, Deslandes E, Villedieu M, Poulain L, Duval M, Gauduchon P, et al. Effect of 2-deoxy-D-glucose on various malignant cell lines in vitro. Anticancer Res 2006; 26:3561-6; PMID:17094483
9. Aft RL, Zhang FW, Gius D. Evaluation of 2-deoxy-Dglucose as a chemotherapeutic agent: mechanism of cell death. Br J Cancer 2002; 87:805-12; PMID: 12232767; http://dx.doi.org/10.1038/sj.bjc.6600547
10. Maher JC, Krishan A, Lampidis TJ. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother Pharmacol 2004; 53: 116-22; PMID:14605866; http://dx.doi.org/10.1007/s00280-003-0724-7
11. Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, et al. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 2004; 64:31-4; PMID:14729604; http://dx.doi.org/10.1158/0008-5472.CAN-03-3294
12. DiPaola RS, Dvorzhinski D, Thalasila A, Garikapaty V, Doram D, May M, et al. Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. Prostate 2008; 68:1743-52; PMID:18767033; http://dx.doi.org/10.1002/pros.20837
13. Xi H, Kurtoglu M, Liu H, Wangpaichitr M, You M, Liu X, et al. 2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion. Cancer Chemother Pharmacol 2011; 67:899-910; PMID:20593179; http://dx.doi.org/10.1007/s00280-010-1391-0
14. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451:1069-75; PMID:18305538; http://dx.doi.org/10.1038/nature06639
15. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004; 306:990-5; PMID:15528435; http://dx.doi.org/10.1126/ science.1099993
16. Wu H, Zhu H, Liu DX, Niu TK, Ren X, Patel R, et al. Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy. Cancer Res 2009; 69:2453-60; PMID:19244119; http://dx.doi.org/10.1158/0008-5472.CAN-08-2872
17. Ben Sahra I, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P, et al. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res 2010; 70:2465-75; PMID:20215500; http://dx.doi.org/10.1158/0008-5472.CAN-09- 2782
18. Gerhäuser C, Mar W, Lee S, Suh N, Luo Y, Kosmeder J, et al. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nat Med 1995; 1:260-6; PMID: 7585044; http://dx.doi.org/10.1038/nm0395-260
19. Fang N, Casida JE. Anticancer action of cubé insecticide: correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities. Proc Natl Acad Sci USA 1998; 95:3380-4; PMID:9520374; http://dx.doi.org/10.1073/pnas.95.7.3380
20. Thamilselvan V, Menon M, Thamilselvan S. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3β/ β-catenin pathway. Int J Cancer 2011. In press. PMID: 21472727; http://dx.doi.org/10.1002/ijc.25949
21. Oh SH, Woo JK, Yazici YD, Myers JN, Kim WY, Jin Q, et al. Structural basis for depletion of heat shock protein 90 client proteins by deguelin. J Natl Cancer Inst 2007; 99:949-61; PMID:17565155; http://dx.doi.org/10.1093/jnci/ djm007
22. Konoshima T, Terada H, Kokumai M, Kozuka M, Tokuda H, Estes JR, et al. Studies on inhibitors of skin tumor promotion, XII. Rotenoids from Amorpha fruticosa. J Nat Prod 1993; 56:843-8; PMID:8350086; http://dx.doi.org/10.1021/ np50096a006
23. Matsuda H, Yoshida K, Miyagawa K, Asao Y, Takayama S, Nakashima S, et al. Rotenoids and flavonoids with anti-invasion of HT1080, anti-proliferation of U937, and differentiation-inducing activity in HL- 60 from Erycibe expansa. Bioorg Med Chem 2007; 15:1539-46; PMID:17158054; http://dx.doi.org/10.1016/j. bmc.2006.09.024
24. Dat NT, Lee JH, Lee K, Hong YS, Kim YH, Lee JJ. Phenolic constituents of Amorpha fruticosa that inhibit NF-kB activation and related gene expression. J Nat Prod 2008; 71:1696-700; PMID:18841906; http://dx.doi.org/10.1021/np800383q
25. Choi S, Choi Y, Dat NT, Hwangbo C, Lee JJ, Lee JH. Tephrosin induces internalization and degradation of EGFR and ErbB2 in HT-29 human colon cancer cells. Cancer Lett 2010; 293:23-30; PMID:20056314; http://dx.doi.org/10.1016/j. canlet.2009.12.012
26. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140:313-26; PMID:20144757; http://dx.doi.org/10.1016/j. cell.2010.01.028
27. Kumar SH, Rangarajan A. Simian virus 40 small T antigen activates AMPK and triggers autophagy to protect cancer cells from nutrient deprivation. J Virol 2009; 83:8565-74; PMID:19515765; http://dx.doi.org/10.1128/JVI.00603-09
28. Wu H, Yang JM, Jin S, Zhang H, Hait WN. Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res 2006; 66:3015-23; PMID:16540650; http://dx.doi.org/10.1158/0008-5472.CAN-05-1554
29. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117:326-36; PMID: 17235397; http://dx.doi.org/10.1172/JCI28833
30. Boya P, González-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 2005; 25:1025-40; PMID:15657430; http://dx.doi.org/10.1128/MCB.25.3.1025- 1040.2005
31. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006; 9:425-34; PMID:16766262; http://dx.doi.org/10.1016/j.ccr.2006. 04.023
32. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452:230-3; PMID:18337823; http://dx.doi.org/10.1038/nature06734
33. Jin Q, Feng L, Behrens C, Bekele BN, Wistuba II, Hong WK, et al. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin. Cancer Res 2007; 67:11630-9; PMID:18089792; http://dx.doi.org/10.1158/0008-5472.CAN-07-2401
34. Gills JJ, Kosmeder J, 2nd, Moon RC, Lantvit DD, Pezzuto JM. Effect of deguelin on UVB-induced skin carcinogenesis. J Chemother 2005; 17:297-301; PMID:16041863
35. Ben Sahra I, Tanti JF, Bost F. The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK dependent apoptosis in prostate cancer cells. Autophagy 2010; 6:670-1; PMID:20559023; http://dx.doi.org/10.4161/auto.6.5.12434
36. Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG. Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase. EMBO J 2001; 20:4370-9; PMID:11500364; http://dx.doi.org/10.1093/emboj/20.16.4370
37. Browne GJ, Proud CG. A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol Cell Biol 2004; 24:2986-97; PMID: 15024086; http://dx.doi.org/10.1128/MCB.24.7.2986-2997.2004
38. Cheng Y, Ren X, Zhang Y, Patel R, Sharma A, Wu H, et al. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res 2011; 71:2654-63; PMID: 21307130; http://dx.doi.org/10.1158/0008-5472.CAN-10-2889